Table 4.

Adjusted Mortality Based on Route of Hysterectomy

Route of hysterectomy	Cancer-Specific Mortality HR (95% CI)	Overall Mortality HR (95% CI)
Minimally invasive versus abdominal hysterectomy
Base model
Abdominal hysterectomy	Referent	Referent
Minimally invasive hysterectomy	0.83 (0.59 to 1.16)	0.89 (0.75 to 1.04)
Adjusted for adjuvant therapy
Abdominal hysterectomy	Referent	Referent
Minimally invasive hysterectomy	0.81 (0.58 to 1.14)	0.88 (0.75 to 1.04)
Stage I base model
Abdominal hysterectomy	Referent	Referent
Minimally invasive hysterectomy	1.01 (0.58 to 1.73)	0.98 (0.78 to 1.21)
Stage I adjusted for adjuvant therapy
Abdominal hysterectomy	Referent	Referent
Minimally invasive hysterectomy	0.97 (0.56 to 1.67)	1.01 (0.77 to 1.19)
Robot-assisted v laparoscopic hysterectomy
Base model
Laparoscopic	Referent	Referent
Robot-assisted	1.53 (0.76 to 3.05)	1.00 (0.72 to 1.41)
Adjusted for adjuvant therapy
Laparoscopic	Referent	Referent
Robot-assisted	1.45 (0.73 to 2.918)	0.97 (0.69 to 1.37)
Stage I base model
Laparoscopic	Referent	Referent
Robot-assisted	1.47 (0.43 to 5.08)	0.92 (0.57 to 1.49)
Stage I adjusted for adjuvant therapy
Laparoscopic	Referent	Referent
Robot-assisted	1.38 (0.39 to 4.82)	0.92 (0.57 to 1.49)

NOTE. Comparison of propensity score balanced groups and adjusted for adjuvant therapy (radiation, brachytherapy, chemotherapy).